Art

J-GLOBAL ID：201402262794296304   Reference number：14A1229774

Changes in Hepcidin and Reticulocyte Hemoglobin Equivalent Levels in Response to Continuous Erythropoietin Receptor Activator Administration in Hemodialysis Patients: A Randomized Study

血液透析患者での持続エリスロポイエチン受容体活性化剤投与への応答におけるヘプシジンと網状赤血球ヘモグロビン等量値の変化 ランダム化試験

Author (5)： KAKIMOTO-SHINO Midori (Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City Univ. Graduate School of Medicine, Yokohama, Kanagawa, JPN) ,  TOYA Yoshiyuki ,  KUJI Tadashi ,  FUJIKAWA Tetsuya ,  UMEMURA Satoshi
Material： Therapeutic Apheresis and Dialysis  (Ther Apheresis Dial)
Volume： 18  Issue： 5  Page： 421-426  Publication year： Oct. 2014 
JST Material Number： W1443A  ISSN： 1744-9979  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *epoetin beta pegol ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1229774&from=J-GLOBAL&jstjournalNo=W1443A") }}

JST classification (2)： Other therapies for urogenital diseases  (GM05040R) ,  Clinical application of drugs acting on blood and body fluid  (GW14020X)

Reference (24)：

• Pisoni RL, Bragg-Gresham JL, Young EW et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44:94-111.
• Richardson D. Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant 2002;17(Suppl): 53-9.
• López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl 2008;111:S75-81.
• Fujikawa T, Ikeda Y, Fukuhara S et al. Time-dependent resistance to erythropoiesis-stimulating agent and mortality in hemodialysis patients in the Japan dialysis outcomes and practice patterns study. Nephron Clin Pract 2012;122:24-32.
• Hörl WH, Jacobs C, Macdougall IC et al. European best practice guidelines 14-16: inadequate response to epoetin. Nephrol Dial Transplant 2000;15(Suppl 4):43-50.

Terms in the title (8)： 血液透析患者 ,  エリスロポイエチン受容体活性化剤 ,  投与 ,  応答 ,  ヘプシジン ,  網状赤血球 ,  ヘモグロビン ,  ランダム化試験